Our Company
Cenra API Solutions (CAS), legally registered as Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is one of Taiwan’s leading API manufacturers with more than 6 decades of experience in pharmaceutical development and production.
In 1984, CAS became the first API manufacturer in Taiwan to pass a U.S. FDA inspection. Today, 29 of our products are registered with the U.S. FDA under Chunghwa Chemical Synthesis & Biotech Co., Ltd., reflecting our strong regulatory capabilities and commitment to global quality standards.
Our goal is to be a reliable and long-term partner for global pharmaceutical companies by delivering high-quality, compliant, and consistently manufactured APIs.
Cenra API Solutions is supported by an experienced team specializing in chemical synthesis, biotechnology, peptide APIs, and commercial‑scale production. With continuous investment in core technologies, we are one of the few API manufacturers in Taiwan that integrates both synthesis and bio-fermentation capabilities, enabling flexible development, scale-up, and commercial manufacturing across diverse API categories supply.
Human-centric Innovation
We innovate with intention, not for novelty, but to meaningfully improve lives. Every new idea, process, and technology we introduce begins with the needs of our patients and partners in mind.
Pursuit of Excellence
There is no room for compromise in health. We hold ourselves to the highest standards because we understand that every product, every service, and every decision can impact lives.
Agility
The healthcare landscape is always changing. We embrace speed and adaptability in both thinking and execution, staying ahead of evolving challenges and opportunities.
Integrity
Trust is the foundation of everything we build. We lead with honesty, transparency, and accountability, earning the confidence of those we serve and work with every day.
More About Us
Cenra API Solutions (CAS), registered as Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is one of Taiwan’s leading API manufacturers, combining chemical synthesis and bio-fermentation technologies to support global pharmaceutical partners. We deliver high-quality, internationally compliant APIs backed by decades of technical expertise.
